Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Halfords names boss of Dixons Carphone's software business as its new CEO from January next year

The FTSE 250-listed retailer said Stapleton will succeed Jill McDonald who is leaving Halfords to run Marks & Spencer PLC's clothing business
Halfords store
McDonald will leave at the end of September and Jonny Mason, Halford's chief financial officer will, in addition, be the group’s interim CEO

Halfords PLC (LON:HFD) has named Graham Stapleton, currently CEO of Dixons Carphone Plc’s (LON:DC.) software business, Honeybee, as its new chief executive with effect from January 15 next year.

The FTSE 250-listed bicycles-to-car-parts retailer said Stapleton will succeed Jill McDonald who is leaving Halfords to run Marks & Spencer PLC's (LON:MKS) clothing business.

READ: Halfords gains as cycling and motoring retail sales see boost from "staycation summer"

Halfords added that McDonald will leave at the end of September and Jonny Mason will be the group’s interim CEO, in addition to his existing role as chief financial officer, with effect from September 22.

Stapleton was CEO of Dixons Carphone's Connected World Services Division from 2015-2017 and CEO of Carphone Warehouse UK & Ireland from 2013-2015.

Until April 2017, he was a member of the Dixons Carphone main board having played a major role in 2015 in the merger and integration of Dixons and Carphone Warehouse.

Dennis Millard, Halfords’ chairman, commented: "Graham is an outstanding business leader with the retail, digital, services and category credentials that are an ideal fit for his role as CEO of Halfords.”

He added: “ We set out our "Moving up a Gear" strategy just under 2 years ago and Graham will continue to drive its implementation and pursue our service-led, growth strategy.”

READ: Halfords gains as cycling and motoring retail sales see boost from "staycation summer"

View full HFD profile View Profile

Halfords Group plc Timeline

Related Articles

H&T Pawnbrokers store
Wed
“We have delivered a strong trading performance during the second half in the key segments of Pawnbroking, Retail and Personal Loans”
Medical tests
July 11 2017
In an operational update, the medical services and software company said a multi-centre investigator led study comprising data from 607 patients at two academic university hospitals has now been completed

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use